TG101348

From Aaushi
Jump to navigation Jump to search
[1]

Indications

Pharmacokinetics

Adverse effects

Mechanism of action

More general terms

References

  1. ↑ Wernig G et al. Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer Cell 2008 Apr; 13:311 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18394554
Retrieved from "https://aaushi.info/w/index.php?title=A5307&oldid=1025861"